Multiple Preclinical Studies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple Preclinical Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple Preclinical Studies Today - Breaking & Trending Today

Chemomab Reports on Two Scientific Presentations that Support the Potential Therapeutic Utility of CM-101 in Systemic Sclerosis

Published: March 14, 2022

—Translational Study Data Presented at 7th Systemic Sclerosis World Congress Confirms CCL24 is Elevated in Diffuse Cutaneous Systemic Sclerosis Patients; High...

Source: prnewswire.com

Related Topics:

Irina KofflerBarbara LindheimWadi MorLifesci AdvisorsScleroderma Programme At Leeds UniversitySystemic Sclerosis World CongressChemomab Therapeutics LtdInternational Rheumatology ConferenceStrategic CommunicationsPrnewswire Chemomab Therapeutics LtdSystemic Sclerosis World Congress ConfirmsUniversity Of LeedsTranslational StudyData PresentedDiffuse Cutaneous Systemic Sclerosis PatientsGreater Disease ActivityWorse PrognosisChemomab Also Presented DataMultiple Preclinical StudiesIsrael DemonstratingPotential Therapeutic UtilitySystemic SclerosisAnti Inflammatory ActivitySystemic Sclerosis LaterChief Scientific Officer

Chemomab Reports on Two Scientific Presentations that Support the Potential Therapeutic Utility of CM-101 in Systemic Sclerosis

Published: March 14, 2022

—Translational Study Data Presented at 7th Systemic Sclerosis World Congress Confirms CCL24 is Elevated in Diffuse Cutaneous Systemic Sclerosis Patients; High...

Source: prnewswire.com

Related Topics:

Irina KofflerBarbara LindheimWadi MorLifesci AdvisorsScleroderma Programme At Leeds UniversitySystemic Sclerosis World CongressChemomab Therapeutics LtdInternational Rheumatology ConferenceStrategic CommunicationsPrnewswire Chemomab Therapeutics LtdSystemic Sclerosis World Congress ConfirmsUniversity Of LeedsTranslational StudyData PresentedDiffuse Cutaneous Systemic Sclerosis PatientsGreater Disease ActivityWorse PrognosisChemomab Also Presented DataMultiple Preclinical StudiesIsrael DemonstratingPotential Therapeutic UtilitySystemic SclerosisAnti Inflammatory ActivitySystemic Sclerosis LaterChief Scientific Officer